Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : LIPO-Liposome -- Ignore unavailable to you. Want to Upgrade?

To: Ted The Technician who wrote (648)	2/1/1999 12:18:00 AM
From: MARK TANAKA	Read Replies (1) \| Respond to of 900

here is press release dated 1/13/99: The Liposome Company Announces That it Expects to Report a Profitable Fourth Quarter SAN FRANCISCO, Jan. 13 /PRNewswire/ -- The Liposome Company, Inc. (Nasdaq-Amex: LIPO) announced today at the 17th Annual Hambrecht & Quist Healthcare Conference that it expects to report an operating profit for the fourth quarter of 1998. This is the Company's first quarterly operating profit in its 17-year history. The improved fourth quarter financial performance can be attributed to strong sales of ABELCET® and increased manufacturing efficiencies. For the nine months ended September 27, 1998, the Company previously reported a loss of $6.2 million or $0.16 per share compared to the 1997 nine-month loss of $19.2 million or $0.52 per share. The Company expects to issue 1998 fourth quarter and full year financial results during the week of February 8, 1999. mark